Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>PTCL R/R * > Treatment > CN. C. HDAC Inhibitor Oral

---

CN. C. HDAC Inhibitor Oral's subsections
(*) CN Approval Date: 2014. 12
(*) JP Approval Date: 2021. 11.30
Company CN
Company JP
Generic Names: Chidamide/Tucidinost
HDAC: Histone DeAcetylace C
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 11.30.
RTM CN
RTM CN Web-Site
RTM JP
RTM JP PR Web-Site

CN. C. HDAC Inhibitor Oral's products
This section has no products